- Bacteriostatic Water is sterile, non-pyrogenic water that contains a small amount of benzyl alcohol (0.9%) as a preservative. It is commonly used in laboratory and research environments as a
Reta (GLP-3) 10mg
$120.00Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
Bacteriostatic Water is sterile, non-pyrogenic water that contains a small amount of benzyl alcohol (0.9%) as a preservative. It is commonly used in laboratory and research environments as a diluent
Reta (GLP-3) 20mg
$195.00Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
BPC-157 10mg
$72.00BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Originally isolated from gastric secretions, this 15-amino acid sequence has been extensively
Tesamorelin 10mg
$86.00Tesamorelin is a synthetic 44–amino-acid polypeptide modeled on growth hormone–releasing hormone (GHRH), incorporating N-terminal and C-terminal modifications to enhance stability and resistance to enzymatic degradation. It binds to GHRH receptors
MOTS-c 10mg
$48.00MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16–amino-acid peptide encoded within the mitochondrial 12S rRNA gene region. It belongs to the family of mitochondrial-derived peptides (MDPs)
The CJC-1295 (No DAC) + Ipamorelin Blend represents a dual-pathway approach to growth hormone (GH) modulation, combining the upstream stimulation of growth hormone–releasing hormone (GHRH) receptors with the downstream activation
Reta (GLP-3) 30mg
$250.00Retatrutide is an investigational multi-agonist peptide engineered to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon—positioning it as a next-generation “triple agonist.” In research settings, it has been
